UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2022 | 2023-02-08 | Future report Set alerts | |
| Q3 2022 | 2022-11-02 | 2.09 | 2.09 |
| Q2 2022 | 2022-08-03 | 2.40 | 2.40 |
| Q1 2022 | 2022-05-04 | 2.22 | 2.22 |
| Q4 2021 | 2022-02-09 | 1.98 | 1.98 |
| Q3 2021 | 2021-11-03 | 1.97 | 1.97 |
| Q2 2021 | 2021-08-04 | 2.42 | 2.42 |
| Q1 2021 | 2021-05-04 | 2.04 | 2.04 |
| Q4 2020 | 2021-02-16 | 1.30 | 1.30 |
| Q3 2020 | 2020-11-06 | 1.66 | 1.66 |
| 2016-07-04 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-06-23 | Reiterated Rating | Mizuho | Buy | $117.00 to $108.00 |
| 2016-06-22 | Boost Price Target | Deutsche Bank | Hold | $99.00 to $105.00 |
| 2016-06-22 | Boost Price Target | Deutsche Bank AG | Hold | $99.00 to $105.00 |
| 2016-06-20 | Downgrade | Morgan Stanley | Overweight to Equal Weight | $111.00 to $104.00 |
| 2016-06-10 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-05 | Reiterated Rating | Credit Suisse | Buy | $115.00 |
| 2016-06-05 | Reiterated Rating | Credit Suisse Group AG | Buy | $115.00 |
| 2016-05-14 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-14 | Reiterated Rating | FBR & Co | Buy | |
| 2016-05-12 | Boost Price Target | Jefferies Group | Buy | $110.00 to $122.00 |
| 2016-05-09 | Boost Price Target | Citigroup Inc. | Neutral | $105.00 to $115.00 |
| 2016-05-05 | Reiterated Rating | Leerink Swann | Buy | $110.00 |
| 2016-05-05 | Reiterated Rating | Macquarie | Outperform | $115.00 |
| 2016-05-04 | Reiterated Rating | RBC Capital | Outperform | $110.00 to $115.00 |
| 2016-05-04 | Reiterated Rating | Mizuho | Buy | $104.00 to $117.00 |
| 2016-05-04 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-04 | Reiterated Rating | Royal Bank Of Canada | Outperform | $110.00 to $115.00 |
| 2016-04-07 | Reiterated Rating | Morgan Stanley | Buy | |
| 2016-03-15 | Reiterated Rating | Morgan Stanley | Overweight | $111.00 |
| 2016-03-15 | Initiated Coverage | Credit Suisse | Outperform | $120.00 to $115.00 |
| 2016-03-10 | Boost Price Target | Barclays | Overweight | $110.00 to $115.00 |
| 2016-03-10 | Boost Price Target | Barclays PLC | Overweight | $110.00 to $115.00 |
| 2016-02-10 | Reiterated Rating | FBR & Co. | Outperform | $120.00 |
| 2016-02-10 | Lower Price Target | Mizuho | Buy | $113.00 to $104.00 |
| 2016-02-10 | Lower Price Target | Guggenheim | Buy | $120.00 to $115.00 |
| 2016-02-10 | Boost Price Target | Goldman Sachs | Neutral | $106.00 to $110.00 |
| 2016-02-10 | Lower Price Target | Deutsche Bank | Hold | $110.00 to $102.00 |
| 2016-02-10 | Boost Price Target | Goldman Sachs Group Inc. | Neutral | $106.00 to $110.00 |
| 2016-02-09 | Reiterated Rating | Leerink Swann | Buy | $125.00 to $110.00 |
| 2016-02-03 | Initiated Coverage | Atlantic Securities | Overweight | $114.00 |
| 2016-01-22 | Initiated Coverage | Robert W. Baird | Outperform | $108.00 |
| 2015-12-19 | Reiterated Rating | Barclays | Buy | |
| 2015-12-18 | Reiterated Rating | Oppenheimer | Buy | |
| 2015-12-18 | Initiated Coverage | Barclays | Buy to Overweight | $113.00 to $110.00 |
| 2015-12-18 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
| 2015-12-17 | Boost Price Target | Oppenheimer | Outperform | $115.00 to $117.00 |
| 2015-12-17 | Downgrade | Goldman Sachs | Buy to Neutral | $113.00 to $106.00 |
| 2015-12-16 | Reiterated Rating | Citigroup Inc. | Hold | $105.00 |
| 2015-11-12 | Lower Price Target | Citigroup Inc. | Neutral | $120.00 to $105.00 |
| 2015-11-03 | Upgrade | S&P Equity Research | Strong-Buy | $121.00 |
| 2015-11-02 | Boost Price Target | RBC Capital | $108.00 to $115.00 | |
| 2015-11-02 | Boost Price Target | Raymond James | Outperform | $105.00 to $110.00 |
| 2015-11-02 | Boost Price Target | Guggenheim | Buy | $110.00 to $115.00 |
| 2015-11-02 | Boost Price Target | BMO Capital Markets | Outperform | $103.00 to $113.00 |
| 2015-11-02 | Reiterated Rating | S&P Equity Research | Strong-Buy | $112.00 |
| 2015-11-02 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $128.00 to $123.00 |
| 2015-11-02 | Lower Price Target | Oppenheimer | Outperform | $122.00 to $115.00 |
| 2015-11-02 | Boost Price Target | Raymond James Financial Inc. | Outperform | $105.00 to $110.00 |
| 2015-10-30 | Lower Price Target | Evercore ISI | Buy | $111.00 to $110.00 |
| 2015-10-30 | Reiterated Rating | Leerink Swann | Buy | $125.00 |
| 2015-10-21 | Lower Price Target | Cowen and Company | $118.00 to $113.00 | |
| 2015-08-28 | Boost Price Target | Oppenheimer | Outperform | $119.00 to $122.00 |
| 2015-08-20 | Reiterated Rating | Deutsche Bank | Hold | $121.00 |
| 2015-08-19 | Reiterated Rating | Evercore ISI | Buy | $113.00 to $118.00 |
| 2015-08-10 | Boost Price Target | Argus | Buy | $114.00 to $118.00 |
| 2015-08-05 | Reiterated Rating | RBC Capital | Outperform | $117.00 to $132.00 |
| 2015-07-22 | Reiterated Rating | Deutsche Bank | Hold | $108.00 to $117.00 |
| 2015-06-26 | Initiated Coverage | Oppenheimer | Outperform | $119.00 |
| 2015-06-23 | Reiterated Rating | Cowen and Company | Outperform | $116.00 |
| 2015-06-17 | Initiated Coverage | Oppenheimer | Outperform | $119.00 |
| 2015-06-16 | Boost Price Target | FBR & Co. | Outperform | $110.00 to $120.00 |
| 2015-06-16 | Upgrade | S&P Equity Research | Buy to Strong-Buy | $121.00 |
| 2015-06-15 | Set Price Target | Credit Suisse | Buy | $110.00 to $114.00 |
| 2015-06-11 | Reiterated Rating | Cowen and Company | Outperform | $108.00 to $116.00 |
| 2015-06-09 | Initiated Coverage | Macquarie | Outperform | $115.00 |
| 2015-05-22 | Upgrade | S&P Equity Research | Buy | |
| 2015-05-22 | Boost Price Target | Jefferies Group | Buy | $120.00 to $125.00 |
| 2015-04-27 | Boost Price Target | Jefferies Group | Buy | $115.00 to $120.00 |
| 2015-02-13 | Boost Price Target | Deutsche Bank | Hold | $100.00 to $109.00 |
| 2015-02-13 | Reiterated Rating | Citigroup Inc. | Hold | $102.00 to $110.00 |
| 2015-02-11 | Downgrade | S&P Equity Research | Hold | |
| 2015-02-11 | Reiterated Rating | Cantor Fitzgerald | Hold | $83.00 |
| 2015-02-11 | Boost Price Target | Argus | Buy | $104.00 to $114.00 |
| 2015-02-11 | Boost Price Target | RBC Capital | Outperform | $108.00 to $115.00 |
| 2015-02-11 | Boost Price Target | Mizuho | Buy | $103.00 to $113.00 |
| 2015-02-10 | Reiterated Rating | Noble Financial | Outperform | |
| 2015-01-21 | Initiated Coverage | Stephens | Overweight | |
| 2015-01-21 | Upgrade | Goldman Sachs | Neutral to Buy | $95.00 to $113.00 |
| 2015-01-08 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $108.00 to $116.00 |
| 2015-01-02 | Set Price Target | Bank of America | Buy | $94.00 to $104.00 |
| 2015-01-02 | Set Price Target | Bank of America Corp. | Buy | $94.00 to $104.00 |
| 2014-12-22 | Set Price Target | Bank of America | Buy | $94.00 to $104.00 |
| 2014-12-19 | Upgrade | SunTrust | Neutral to Buy | $92.00 to $110.00 |
| 2014-12-19 | Upgrade | SunTrust Banks Inc. | Neutral to Buy | $92.00 to $110.00 |
| 2014-12-18 | Reiterated Rating | Argus | Buy | $95.00 to $105.00 |
| 2014-12-17 | Boost Price Target | Credit Suisse | Outperform | $95.00 to $101.00 |
| 2014-12-17 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $92.00 to $108.00 |
| 2014-12-17 | Boost Price Target | Barclays | Overweight | $98.00 to $107.00 |
| 2014-12-17 | Boost Price Target | RBC Capital | Outperform | $96.00 to $103.00 |
| 2014-12-10 | Initiated Coverage | Citigroup Inc. | Neutral | $99.00 |
| 2014-11-12 | Boost Price Target | Mizuho | Buy | $85.00 to $103.00 |
| 2014-11-05 | Reiterated Rating | Deutsche Bank | Hold | $84.00 to $90.00 |
| 2014-11-05 | Reiterated Rating | FBR & Co. | Outperform | $90.00 to $92.00 |
| 2014-11-05 | Boost Price Target | Argus | Buy | $85.00 to $95.00 |
| 2014-11-05 | Boost Price Target | RBC Capital | Outperform | $86.00 to $96.00 |
| 2014-09-15 | Upgrade | Cowen and Company | Market Perform to Outperform | $85.00 to $92.00 |
| 2014-08-06 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $82.00 to $91.00 |
| 2014-08-06 | Boost Price Target | Cantor Fitzgerald | $66.00 to $71.00 | |
| 2014-08-06 | Boost Price Target | Morgan Stanley | $81.00 to $85.00 | |
| 2014-08-06 | Boost Price Target | Barclays | $85.00 to $87.00 | |
| 2014-08-06 | Boost Price Target | Leerink Swann | $85.00 to $87.00 | |
| 2014-08-06 | Boost Price Target | Argus | Buy | $83.00 to $85.00 |
| 2014-08-06 | Boost Price Target | RBC Capital | Outperform | $76.00 to $86.00 |
| 2014-08-06 | Boost Price Target | Mizuho | Buy | $81.00 to $85.00 |
| 2014-08-06 | Boost Price Target | Cowen and Company | $80.00 to $85.00 | |
| 2014-08-05 | Reiterated | ISI Group | Strong Buy | $86 to $88 |
| 2014-08-05 | Downgrade | Evercore ISI | Underperform | $86.00 to $54.00 |
| 2014-06-06 | Boost Price Target | Susquehanna | Positive | $85.00 to $90.00 |
| 2014-05-28 | Boost Price Target | Deutsche Bank | $80.00 to $83.00 | |
| 2014-05-28 | Reiterated Rating | Morgan Stanley | Overweight | $80.00 |
| 2014-05-19 | Initiated Coverage | Standpoint Research | Strong Sell to Sell | $62.00 |
| 2014-05-05 | Boost Price Target | Barclays | Overweight | $74.00 to $85.00 |
| 2014-04-29 | Boost Price Target | Susquehanna | Positive | $80.00 to $85.00 |
| 2014-04-09 | Boost Price Target | FBR & Co. | $80.00 to $84.00 | |
| 2014-04-04 | Boost Price Target | Argus | Buy | $77.00 to $83.00 |
| 2014-02-13 | Boost Price Target | Susquehanna | $71.00 to $80.00 | |
| 2014-02-13 | Boost Price Target | Guggenheim | $75.00 to $77.00 | |
| 2014-01-22 | Upgrade | Evercore ISI | Buy to Strong-Buy | $78.50 |
| 2014-01-09 | Initiated Coverage | Leerink Swann | Outperform | $85.00 |
| 2013-12-20 | Reiterated Rating | Deutsche Bank | Hold | $71.00 to $76.00 |
| 2013-12-19 | Boost Price Target | Argus | Buy | $70.00 to $77.00 |
| 2013-12-19 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $82.00 |
| 2013-12-19 | Boost Price Target | RBC Capital | Outperform | $71.00 to $76.00 |
| 2013-12-19 | Boost Price Target | FBR & Co. | Outperform | $72.00 to $80.00 |
| 2013-12-19 | Boost Price Target | Mizuho | Buy | $74.00 to $81.00 |
| 2013-12-19 | Boost Price Target | Jefferies Group | $71.00 to $81.00 | |
| 2013-12-18 | Reiterated Rating | Evercore ISI | In-Line | |
| 2013-12-17 | Boost Price Target | Goldman Sachs | Neutral | $68.00 to $72.00 |
| 2013-12-16 | Boost Price Target | Guggenheim | $60.00 to $75.00 | |
| 2013-12-12 | Reiterated Rating | Credit Suisse | Outperform | |
| 2013-12-04 | Boost Price Target | Mizuho | Buy | $70.00 to $74.00 |
| 2013-11-29 | Reiterated Rating | Morgan Stanley | Overweight | $65.00 |
| 2013-11-20 | Initiated Coverage | Deutsche Bank | Hold to Hold | $51.00 to $71.00 |
| 2013-11-06 | Boost Price Target | Mizuho | Buy | $66.00 to $70.00 |
| 2013-11-06 | Reiterated | FBR Capital | Outperform | $69 to $72 |
| 2013-11-06 | Boost Price Target | SunTrust | Neutral | $66.00 to $70.00 |
| 2013-11-06 | Boost Price Target | Raymond James | Outperform | $65.00 to $70.00 |
| 2013-11-06 | Boost Price Target | BMO Capital Markets | Outperform | $66.00 to $70.00 |
| 2013-11-06 | Boost Price Target | FBR & Co. | Outperform | $69.00 to $72.00 |
| 2013-11-05 | Reiterated | ISI Group | Buy | $67 to $70.50 |
| 2013-11-05 | Reiterated Rating | FBR & Co. | Buy | $69.00 |
| 2013-11-05 | Boost Price Target | Evercore ISI | Buy | $67.00 to $70.50 |
| 2013-10-24 | Initiated Coverage | FBR & Co. | Outperform to Outperform | $69.00 |
| 2013-10-07 | Initiated Coverage | Jefferies Group | Buy | $71.00 |
| 2013-07-09 | Reiterated | Mizuho | Buy | $56 to $64 |
| 2013-05-02 | Reiterated | Cantor Fitzgerald | Buy | $57 to $65 |
| 2016-07-04 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-06-23 | Reiterated Rating | Mizuho | Buy | $117.00 to $108.00 |
| 2016-06-22 | Boost Price Target | Deutsche Bank | Hold | $99.00 to $105.00 |
| 2016-06-22 | Boost Price Target | Deutsche Bank AG | Hold | $99.00 to $105.00 |
| 2016-06-20 | Downgrade | Morgan Stanley | Overweight to Equal Weight | $111.00 to $104.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CVS 1355 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 0.12B |
| BlackRock Inc. | 93.85M |
| Capital World Investors | 60.90M |
| STATE STREET CORP | 58.34M |
| MORGAN STANLEY | 30.26M |
| BlackRock Institutional Trust Company, N.A. | 30.13M |
| JPMORGAN CHASE & CO | 25.91M |
| Capital International Investors | 25.91M |
| GEODE CAPITAL MANAGEMENT, LLC | 23.37M |
| BANK OF AMERICA CORP /DE/ | 19.29M |
| Invesco Ltd. | 17.15M |
| AMERIPRISE FINANCIAL INC | 15.18M |
| NORTHERN TRUST CORP | 14.70M |
| BlackRock Fund Advisors | 14.30M |
| ROYAL BANK OF CANADA | 14.12M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| MERLO LARRY J President and CEO | 0.03% (330107) | CVS / |
| Roberts Jonathan C EVP & President, Caremark | 0.01% (162911) | CVS / |
| DORMAN DAVID W | 0.01% (104638) | CVS / DVMT / EBAY / MSI / PYPL / YUM / |
| BROWN C DAVID II | 0.01% (101252) | CVS / ESI / RYAM / RYN / |
| Kraft Robert O. EVP and President - Omnicare | 0.01% (92360) | CVS / OCR / |
| Brennan Troyen A EVP, Chief Medical Officer | 0.01% (84723) | CVS / |
UM